Shandong Intco Medical Products Co Ltd (300677) — Capital Reinvestment Ratio
Shandong Intco Medical Products Co Ltd (300677) has a Capital Reinvestment Ratio of 1.73x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥451.59 Million) in capital expenditures (CN¥782.15 Million). See 300677 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Intco Medical Products Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Shandong Intco Medical Products Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check total reinvestment intensity of Shandong Intco Medical Products Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Intco Medical Products Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Intco Medical Products Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see market value of Shandong Intco Medical Products Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.66x | CN¥1.08 Billion | CN¥1.79 Billion | ▼ -42.1% |
| 2023 | 2.86x | CN¥502.41 Million | CN¥1.44 Billion | ▲ +77.9% |
| 2022 | 1.61x | CN¥1.07 Billion | CN¥1.72 Billion | ▲ +156.7% |
| 2021 | 0.63x | CN¥8.68 Billion | CN¥5.44 Billion | ▲ +86.5% |
| 2020 | 0.34x | CN¥8.59 Billion | CN¥2.89 Billion | ▼ -79.3% |
| 2019 | 1.63x | CN¥329.69 Million | CN¥536.57 Million | ▼ -2.0% |
| 2018 | 1.66x | CN¥185.78 Million | CN¥308.55 Million | ▲ +93.7% |
| 2017 | 0.86x | CN¥247.48 Million | CN¥212.22 Million | ▼ -68.8% |
| 2016 | 2.74x | CN¥78.46 Million | CN¥215.36 Million | ▲ +45.1% |
| 2015 | 1.89x | CN¥76.29 Million | CN¥144.36 Million | ▲ +195.3% |
| 2014 | 0.64x | CN¥77.28 Million | CN¥49.52 Million | ▼ -30.5% |
| 2013 | 0.92x | CN¥74.52 Million | CN¥68.73 Million | — |